Healthcare Inequities in the LGBTQ+ Community and Investigations in Respiratory Care
-
By
-
RC Central Editorial Team
-
June 11, 2026
By
RC Central Editorial Team
June 11, 2026
by RC Central Editorial Team
June 11, 2026
Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.
June 25, 2026
The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.
August 28, 2026